[The combined therapy of carboplatin, fluorouracil and radiotherapy for moderate and advanced non-small cell lung cancer].
To observe the effect of combined chemotherapy (carboplatin and fluorouracil) with radiotherapy for moderate and advanced non-small cell lung cancer. Eighty patients with moderate and advanced non-small cell lung cancer were randomized into 2 groups, radiotherapy group(R) and carboplatin, fluorouracil plus radiotherapy group (CF + R). All patients in two groups received conventional radiotherapy. Patients in CF + R group received combined chemotherapy with carboplatin(100 mg, d 1-5) 5-fluorouracil(500 mg d 1-5) in the first and fourth weeks during radiotherapy. The complete response rate was 48% in CF + R group, 25% in R group. The 1-year, 3-year, 5-year survival rates were 63%, 38%, 18% in CF + R group, and 40%, 15%, 8% in R group. The major toxic reactions in CF + R group were grade I-II myelo-suppression and digestive tract reaction. Combined chemotherapy(carboplatin and fluorouracil) with radiotherapy is preferable for non-small cell lung cancer.